From: Association of LIN28B polymorphisms with chronic hepatitis B virus infection
 | Patients (n = 515) | Resolvers (n = 97) | Controls (n = 169) | Patients vs. resolvers | Patients vs. controls | Resolvers vs. controls | ||||
---|---|---|---|---|---|---|---|---|---|---|
P | OR (95%CI) | P | OR (95%CI) | P | OR (95%CI) | |||||
Genotype | ||||||||||
 Codominant | TT | 317 (61.6) | 50 (51.5) | 85 (50.3) | Reference |  | Reference |  | Reference |  |
TC | 166 (32.2) | 38 (39.2) | 75 (44.4) | 0.113 | 0.689 (0.434–1.093) | 0.005a | 0.593 (0.413–0.853) | 0.576 | 0.861 (0.510–1.454) | |
CC | 32 (6.2) | 9 (9.3) | 9 (5.3) | 0.150 | 0.561 (0.253–1.245) | 0.904 | 0.953 (0.438–2.074) | 0.289 | 1.700 (0.633–4.565) | |
 Dominant | TT | 317 (61.6) | 50 (51.5) | 85 (50.3) | Reference |  | Reference |  | Reference |  |
TC + CC | 198 (38.4) | 47 (48.5) | 84 (49.7) | 0.065 | 0.664 (0.430–1.028) | 0.010 | 0.632 (0.445–0.897) | 0.844 | 0.951 (0.577–1.567) | |
 Recessive | TT + TC | 483 (93.8) | 88 (90.7) | 160 (94.7) | Reference |  | Reference |  | Reference |  |
CC | 32 (6.2) | 9 (9.3) | 9 (5.3) | 0.271 | 0.648 (0.299–1.404) | 0.673 | 1.178 (0.550–2.521) | 0.222 | 1.818 (0.696–4.748) | |
 Overdominant | TT + CC | 349 (67.8) | 59 (60.8) | 94 (55.6) | Reference |  | Reference |  | Reference |  |
TC | 166 (32.2) | 38 (39.2) | 75 (44.4) | 0.184 | 0.739 (0.472–1.155) | 0.004 | 0.594 (0.418–0.850) | 0.409 | 0.807 (0.486–1.342) | |
 Additive |  | – | – | – | 0.058 | 0.725 (0.520–1.010) | 0.033 | 0.741 (0.562–0.977) | 0.848 | 0.962 (0.645–1.435) |
Allele | ||||||||||
 | T | 800 (77.7) | 138 (71.1) | 245 (72.5) | Reference |  | Reference |  | Reference |  |
C | 230 (22.3) | 56 (28.9) | 93 (27.5) | 0.048 | 0.708 (0.503–0.999) | 0.051 | 0.757 (0.572–1.002) | 0.738 | 1.069 (0.723–1.582) |